A National Institutes of Health-funded study found that 21 existing drugs show potential in treating COVID-19 patients and four of those medications, coupled with remdesivir, can be repurposed to help block coronavirus infections, NIH Director Francis Collins said in a Tuesday (Aug. 4) press release. According to Collins, the study suggests there may be multiple therapies, both experimental and existing, that can be potentially repurposed to treat COVID-19 patients, and some may even work well coupled with other drugs as...